Thank you

This live web event has ended. Thank you for attending.

Description

Homologous Recombination Deficiency
and BRCA Testing in Ovarian and Breast Cancer

Also hosted before a live audience at CAP18 in Chicago, IL
Hyatt Regency, Chicago, Illinois
Ballroom: Crystal A, Lobby Level, West Tower

Why should you register now for this webinar?
Hear national thought leaders discuss the following topics:

• The role of BRCA1/2 mutations in homologous recombination
  deficiency and carcinogenesis
• Homologous recombination deficiency as a marker of treatment sensitivity
• The testing process for homologous recombination deficiency and BRCA mutations
• The role of BRCA testing in ovarian and breast cancer

Brought to you by CAP TODAY
Moderator: Bob McGonnagle, Publisher, CAP TODAY
Presenters: Dana Chase, MD, FACOG; Michelle Shiller, DO, MSPT; and Tabetha Sundin, PhD, HCLD(ABB), MB(ASCP)^CM.
You will have the opportunity to ask questions of our distinguished presenters.

CAP TODAY does not endorse any of the products or services named within.
©2018 AstraZeneca. All rights reserved.